Cel Sci (CVM) EPS (Diluted) (QoQ) (2010 - 2026)
Cel Sci (CVM) EPS (Diluted) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - |
| 10 | Cel Sci | 2.18 Mn | -4.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.57% |
| Dec 31, 2025 | 54.64% |
| Sep 30, 2025 | -10.22% |
| Jun 30, 2025 | 41.49% |
| Mar 31, 2025 | 28.20% |
| Dec 31, 2024 | 4.22% |
| Sep 30, 2024 | 18.78% |
| Jun 30, 2024 | 0.09% |
| Mar 31, 2024 | -0.64% |
| Dec 31, 2023 | 19.31% |
| Sep 30, 2023 | 8.88% |
| Jun 30, 2023 | -0.29% |
| Mar 31, 2023 | -3.96% |
| Dec 31, 2022 | 14.34% |
| Sep 30, 2022 | 8.31% |
| Jun 30, 2022 | -0.84% |
| Mar 31, 2022 | -11.85% |
| Dec 31, 2021 | -1.11% |
| Sep 30, 2021 | 9.67% |
| Jun 30, 2021 | 23.29% |